
|Articles|September 15, 2015
Gregory J. Riely on the Identification and Treatment of MET Exon 14 Skipping Mutations
Author(s)Gregory J. Riely
Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.
Advertisement
Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
All FDA Oncology Approvals From September 2025
2
FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer
3
Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness
4
FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care
5